YU41740B - Process for obtaining new antiinflammatory and immunoregulating pyridines and pyrimidines - Google Patents

Process for obtaining new antiinflammatory and immunoregulating pyridines and pyrimidines

Info

Publication number
YU41740B
YU41740B YU2626/80A YU262680A YU41740B YU 41740 B YU41740 B YU 41740B YU 2626/80 A YU2626/80 A YU 2626/80A YU 262680 A YU262680 A YU 262680A YU 41740 B YU41740 B YU 41740B
Authority
YU
Yugoslavia
Prior art keywords
pyridine
pyridines
immunoregulating
pyrimidines
hydroxyethylthiomethyl
Prior art date
Application number
YU2626/80A
Other languages
English (en)
Other versions
YU262680A (en
Inventor
J G Lombardino
C A Harbert
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU262680A publication Critical patent/YU262680A/xx
Publication of YU41740B publication Critical patent/YU41740B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01D—HARVESTING; MOWING
    • A01D34/00—Mowers; Mowing apparatus of harvesters
    • A01D34/001—Accessories not otherwise provided for
    • A01D34/003—Means for cleaning the machine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C33/00—Moulds or cores; Details thereof or accessories therefor
    • B29C33/56—Coatings, e.g. enameled or galvanised; Releasing, lubricating or separating agents
    • B29C33/60—Releasing, lubricating or separating agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C70/00—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
    • B29C70/68—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks
    • B29C70/84—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks by moulding material on preformed parts to be joined
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/0604—Construction of the male part
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/068—Special features relating to lubrication

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Composite Materials (AREA)
  • Environmental Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
YU2626/80A 1979-10-15 1980-10-13 Process for obtaining new antiinflammatory and immunoregulating pyridines and pyrimidines YU41740B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/085,011 US4246263A (en) 1979-10-15 1979-10-15 Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions

Publications (2)

Publication Number Publication Date
YU262680A YU262680A (en) 1983-09-30
YU41740B true YU41740B (en) 1987-12-31

Family

ID=22188737

Family Applications (2)

Application Number Title Priority Date Filing Date
YU2626/80A YU41740B (en) 1979-10-15 1980-10-13 Process for obtaining new antiinflammatory and immunoregulating pyridines and pyrimidines
YU2668/82A YU42059B (en) 1979-10-15 1982-12-01 Process for obtaining newantrinflammatory and immunoregulating pyridines and pyrimidine

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU2668/82A YU42059B (en) 1979-10-15 1982-12-01 Process for obtaining newantrinflammatory and immunoregulating pyridines and pyrimidine

Country Status (39)

Country Link
US (1) US4246263A (el)
JP (1) JPS5663962A (el)
KR (2) KR840001614B1 (el)
AR (3) AR226864A1 (el)
AT (2) AT377513B (el)
AU (1) AU517763B2 (el)
BE (1) BE885709A (el)
CA (1) CA1156231A (el)
CH (1) CH646425A5 (el)
CS (2) CS226020B2 (el)
DD (2) DD154816B3 (el)
DE (1) DE3038593A1 (el)
DK (1) DK152427C (el)
EG (1) EG14676A (el)
ES (2) ES8201972A1 (el)
FI (1) FI75560C (el)
FR (1) FR2467199A1 (el)
GB (2) GB2092133B (el)
GR (1) GR70311B (el)
HK (2) HK1185A (el)
HU (2) HU191824B (el)
IE (1) IE50665B1 (el)
IL (1) IL61261A (el)
IN (2) IN154554B (el)
IT (1) IT1195269B (el)
KE (2) KE3461A (el)
LU (1) LU82844A1 (el)
MY (2) MY8500323A (el)
NL (1) NL8005652A (el)
NO (1) NO156566C (el)
NZ (1) NZ195246A (el)
PH (1) PH18277A (el)
PL (2) PL125402B1 (el)
PT (1) PT71917B (el)
SE (1) SE437023B (el)
SG (2) SG56384G (el)
SU (2) SU1083907A3 (el)
YU (2) YU41740B (el)
ZA (1) ZA806306B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371696A (en) * 1980-07-14 1983-02-01 Pfizer Inc. Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof
GB8405896D0 (en) * 1984-03-07 1984-04-11 Sandoz Ltd Organic compounds
EP0311616B1 (en) * 1986-06-17 1991-09-25 Biogen, Inc. Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents for treating diseases
US6878743B2 (en) * 2001-09-18 2005-04-12 Sunesis Pharmaceuticals, Inc. Small molecule inhibitors of caspases
AU2006216544B2 (en) * 2005-02-25 2012-04-05 Onconova Therapeutics, Inc. Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis
TW200917961A (en) * 2007-08-23 2009-05-01 Sumitomo Chemical Co Fluorine-containing organosulfur compound and pesticidal composition thereof
CN108530606B (zh) * 2018-04-19 2020-11-20 山东师范大学 一种pH敏感性医用聚氨酯脲材料及其制备方法
CN110483740B (zh) * 2019-08-12 2021-08-27 山东师范大学 一种聚合物、pH敏感性纳米囊泡及制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409626A (en) * 1963-09-17 1968-11-05 Neisler Lab Inc Indolylethyl pyridinium quaternary ammonium compounds
NL144484B (nl) * 1967-07-26 1975-01-15 Merck & Co Inc Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren.
US3558640A (en) * 1967-12-20 1971-01-26 Merck & Co Inc Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives
US3636074A (en) * 1968-08-05 1972-01-18 Hooker Chemical Corp Novel mercaptophenol derivatives
US3591584A (en) 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3818009A (en) * 1969-12-29 1974-06-18 Lilly Co Eli Alpha, alpha-disubstituted-5-pyrimidinemethanes
US3676463A (en) 1970-10-15 1972-07-11 Pfizer Oxobenzofuran carboxamides
US3707475A (en) 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives

Also Published As

Publication number Publication date
ES495932A0 (es) 1982-01-16
HU191824B (en) 1987-04-28
KR840001615B1 (ko) 1984-10-11
EG14676A (en) 1985-03-31
SG56384G (en) 1985-03-08
AR226864A1 (es) 1982-08-31
NL8005652A (nl) 1981-04-21
ES505544A0 (es) 1982-08-16
NZ195246A (en) 1983-07-15
FR2467199B1 (el) 1984-12-28
PT71917B (en) 1983-01-10
IN154554B (el) 1984-11-10
FI75560C (fi) 1988-07-11
DK152427B (da) 1988-02-29
HU183233B (en) 1984-04-28
DD154816A5 (de) 1982-04-21
SU1144617A3 (ru) 1985-03-07
GR70311B (el) 1982-09-08
HK66887A (en) 1987-09-25
IT1195269B (it) 1988-10-12
IL61261A (en) 1984-08-31
DD154816B3 (de) 1987-05-13
FR2467199A1 (fr) 1981-04-17
ZA806306B (en) 1981-10-28
FI803239L (fi) 1981-04-16
MY8500325A (en) 1985-12-31
AR227576A1 (es) 1982-11-15
NO156566B (no) 1987-07-06
GB2092133A (en) 1982-08-11
SU1083907A3 (ru) 1984-03-30
HK1185A (en) 1985-01-11
AU517763B2 (en) 1981-08-27
GB2092133B (en) 1983-03-16
AU6324080A (en) 1981-04-30
JPS5663962A (en) 1981-05-30
ATA268783A (de) 1985-07-15
PH18277A (en) 1985-05-17
KR840001614B1 (ko) 1984-10-11
PL227307A1 (el) 1981-11-13
CH646425A5 (fr) 1984-11-30
AR227089A1 (es) 1982-09-15
DK403080A (da) 1981-04-16
IE802125L (en) 1981-04-15
GB2061928A (en) 1981-05-20
NO803073L (no) 1981-04-21
DE3038593A1 (de) 1981-04-23
YU262680A (en) 1983-09-30
IL61261A0 (en) 1980-12-31
SG69184G (en) 1985-03-15
DK152427C (da) 1988-07-25
FI75560B (fi) 1988-03-31
KE3461A (en) 1984-10-12
IN163553B (el) 1988-10-08
CS226020B2 (en) 1984-03-19
CA1156231A (en) 1983-11-01
AT377513B (de) 1985-03-25
YU266882A (en) 1983-09-30
PL125402B1 (en) 1983-05-31
AT379801B (de) 1986-03-10
CS226034B2 (en) 1984-03-19
DD202543A5 (de) 1983-09-21
IT8025324A0 (it) 1980-10-14
MY8500323A (en) 1985-12-31
SE437023B (sv) 1985-02-04
YU42059B (en) 1988-04-30
GB2061928B (en) 1983-06-02
ATA508980A (de) 1984-08-15
ES8201972A1 (es) 1982-01-16
PL125314B1 (en) 1983-04-30
ES8206478A1 (es) 1982-08-16
JPS6129342B2 (el) 1986-07-05
KE3466A (en) 1984-11-09
KR830004263A (ko) 1983-07-09
IE50665B1 (en) 1986-06-11
DE3038593C2 (el) 1988-11-10
PT71917A (en) 1980-12-01
US4246263A (en) 1981-01-20
SE8007193L (sv) 1981-04-16
LU82844A1 (fr) 1981-06-04
PL231782A1 (el) 1982-03-01
BE885709A (fr) 1981-04-14
NO156566C (no) 1987-10-14

Similar Documents

Publication Publication Date Title
IT7851566A0 (it) Azabiciclo(3/2/0)-ept-2-ene-2-carprocedimento per la produzione di bossilico 3-sostituito acido 6-(1-idrossietil)-7-osso-1-
YU266882A (en) Process for obtaining new antiinflammatory and immunoregulating pyridines and pyrimidines
AU576913B2 (en) Substituted -2,6- substituted pyridine compounds
SU913941A3 (en) Process for producing cis-derivatives of pyridine or their pharmaceutically acceptable acid salts
IE780279L (en) Imidazole derivatives
PT66788A (en) Process for the preparation of novel herbicidally active phenoxy-alkanecarboxylic acid derivatives and use thereof for controlling grass-like weeds
IE812748L (en) Pyridine derivatives as anti-inflammatory and¹immunoregulatory agents
EP0016255A3 (en) Isoxazole derivative, preparation thereof, pharmaceutical compositions containing same and intermediates for its preparation
PT68327A (en) Process for preparing 4-(5-fluoromethyl-2-pyridyloxi)- -phenoxyalkanecarboxylic acids and derivatives thereof useful as herbicides
ES2076818T3 (es) Procedimiento para la preparacion de acidos de 2,3-piridindicarboxilicos a partir de acidos 3-(2-imidazolin-2-il)picolinicos.
MX156101A (es) Proceso para la preparacion de esteres del acido 6-metil nicotinico
ES465207A1 (es) Procedimiento para la preparacion de derivados de acidos pi-rrolo-benzoicos.
JPS53108951A (en) Cyclopropanecarboxylic acid derivative and its production
IE792294L (en) Process for the preparation of 2-ketogulonic acid.
IT1092159B (it) Procedimento per la preparazione di un derivato solforato dell'acido nicotinico ad azione epatoprotettrice
JPS5444677A (en) Nicotinic acid ester derivative
IL59627A (en) Esters of 6-substituted pyrimidine-2,4-dicarbamic acid 3-oxides
YU40493B (en) Process for the preparation of a stable, crude pectionalytic enzymatic preparation from the fermentation broth of citric acid